 |
|
 |
NIDA And Partners Announce National Initiative On Prescription Drug Misuse And Abuse
The National Institute on Drug Abuse (NIDA) and several national organizations announced yesterday a public health initiative to raise awareness about recent trends in the misuse and abuse of prescription drugs in the United States. The initiative seeks to inform the public, physicians, pharmacists, and others about the misuse and abuse of medications and promote additional research on the subject. more |
|
New Research Report: Prescription Drugs - Abuse And Addiction
Vidyya is pleased to offer a new NIDA report on the subject of prescription drugs to our readers. While prescription drug abuse is not a new problem, it is one that deserves renewed attention. This scientific report is designed to be useful to the public, particularly to individuals working with the elderly, who because of the number of medications they may take for various medical conditions, may be more vulnerable to misuse or abuse of prescribed medications. more |
|
|
|
Best Leads For Prostate Cancer Prevention Appear In April "Urology" Supplement
The most promising agents to prevent prostate cancer and the most likely biological markers of risk for the disease are just two of the key areas of prostate cancer prevention research highlighted in the supplement to the April issue of the journal Urology, "New Clinical Trial Strategies for Prostate Cancer Prevention." Capturing the recent advances in the converging fields of cancer chemoprevention and preventive urologic oncology, the science published in this journal aims to stimulate and guide research in this crucial area. more |
|
Drug Watch: Three Medical Journals Publish Papers Lupus Drug Candidate
Three recent papers discuss the clinical development of a new lupus drug candidate, LJP 394. Information appears in: Lupus, Expert Opinion of Investigational Drugs, and The Journal of Rheumatology. The pharmaceutical company that manufactures the drug is currently conducting a Phase III trial designed to confirm the ability of LJP 394 to treat lupus kidney disease. more |
|
Article Published In American Journal of Cardiology Demonstrates Safety And Effectiveness of Excimer Laser Coronary Angioplasty
The 01 April issue of the American Journal of Cardiology contains an article demonstrating the safety and effectiveness of excimer laser coronary angioplasty to treat a subset of patients with acute coronary syndromes. The article entitled "Effectiveness of Excimer Laser Coronary Angioplasty in Acute Myocardial Infarction or in Unstable Angina Pectoris" evaluated the feasibility, safety, and acute results of percutaneous excimer laser coronary angioplasty (ELCA) in acute coronary syndromes. more |
|
|
